Cargando…

Valsartan Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism: A randomized controlled trial

OBJECTIVE: Recently, the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial demonstrated that treatment with the angiotensin receptor blocker (ARB) valsartan for 5 years resulted in a relative reduction of 14% in the incidence of type 2 diabetes in subjects with impaired...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Zijl, Nynke J., Moors, Chantalle C.M., Goossens, Gijs H., Hermans, Marc M.H., Blaak, Ellen E., Diamant, Michaela
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064038/ https://www.ncbi.nlm.nih.gov/pubmed/21330640 http://dx.doi.org/10.2337/dc10-2224

Ejemplares similares

Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose
por: Goossens, Gijs H., et al.
Publicado: (2016)

Valsartan Improves Adipose Tissue Function in Humans with Impaired Glucose Metabolism: A Randomized Placebo-Controlled Double-Blind Trial
por: Goossens, Gijs H., et al.
Publicado: (2012)

Unraveling the Pathophysiology of Obesity-Related Insulin Resistance—A Perspective on “Adipose Tissue Inflammation Is Directly Linked to Obesity-Induced Insulin Resistance, while Gut Dysbiosis and Mitochondrial Dysfunction Are Not Required”
por: Goossens, Gijs H, et al.
Publicado: (2020)

The angiotensin II type 1 receptor blocker valsartan in the battle against COVID‐19
por: de Ligt, Marlies, et al.
Publicado: (2021)

Adipose Tissue Dysfunction and Impaired Metabolic Health in Human Obesity: A Matter of Oxygen?
por: Goossens, Gijs H., et al.
Publicado: (2015)

The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis
por: Pang, Michelle D., et al.
Publicado: (2021)

Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension
por: Engeli, Stefan, et al.
Publicado: (2018)

Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions
por: Trouwborst, Inez, et al.
Publicado: (2018)

Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans
por: Ding, Lingling, et al.
Publicado: (2019)

Metabolic phenotyping in people living with obesity: Implications for dietary prevention
por: Blaak, Ellen E., et al.
Publicado: (2023)

Altered skeletal muscle fatty acid handling is associated with the degree of insulin resistance in overweight and obese humans
por: van der Kolk, Birgitta W., et al.
Publicado: (2016)

Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males
por: Hermes, Gerben D. A., et al.
Publicado: (2020)

Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance
por: Jocken, Johan W. E., et al.
Publicado: (2013)

Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects : Effect of β-Adrenergic Stimulation
por: Jocken, Johan W.E., et al.
Publicado: (2008)

Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans
por: Müller, Mattea, et al.
Publicado: (2019)

Improved quantification of muscle insulin sensitivity using oral glucose tolerance test data: the MISI Calculator
por: O’Donovan, Shauna D., et al.
Publicado: (2019)

Vitamin D release across abdominal adipose tissue in lean and obese men: The effect of ß‐adrenergic stimulation
por: Pramono, Adriyan, et al.
Publicado: (2019)

Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health
por: Jardon, Kelly M, et al.
Publicado: (2022)

Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
por: Rhee, Sang Youl, et al.
Publicado: (2007)

A 3-day EGCG-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects
por: Most, Jasper, et al.
Publicado: (2015)

Sexual Dimorphism in Body Weight Loss, Improvements in Cardiometabolic Risk Factors and Maintenance of Beneficial Effects 6 Months after a Low-Calorie Diet: Results from the Randomized Controlled DiOGenes Trial
por: Trouwborst, Inez, et al.
Publicado: (2021)

Cassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose tolerance
por: Wickenberg, Jennie, et al.
Publicado: (2014)

Indoxyl sulfate impairs valsartan-induced neovascularization()
por: Kuo, Ko-Lin, et al.
Publicado: (2020)

Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese
por: Mitsui, Rie, et al.
Publicado: (2012)

Cathepsin gene expression in abdominal subcutaneous adipose tissue of obese/overweight humans
por: Xu, Qing, et al.
Publicado: (2020)

Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children
por: van Vliet, Mariska, et al.
Publicado: (2010)

The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview
por: van Sloun, Bart, et al.
Publicado: (2020)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
por: Preiss, David, et al.
Publicado: (2012)

The effects of angiotensin receptor neprilysin inhibition by sacubitril/valsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients
por: Stinkens, R., et al.
Publicado: (2018)

Resveratrol supplementation reduces ACE2 expression in human adipose tissue
por: de Ligt, Marlies, et al.
Publicado: (2021)

Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues
por: Baena, Miguel, et al.
Publicado: (2016)

Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose tolerance
por: Gómez-Sámano, Miguel Ángel, et al.
Publicado: (2017)

Changes in Insulin Secretion and Insulin Sensitivity in Relation to the Glycemic Outcomes in Subjects With Impaired Glucose Tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1)
por: Snehalatha, Chamukuttan, et al.
Publicado: (2009)

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance
por: Aoyama-Sasabe, Sae, et al.
Publicado: (2016)

The Effects of Mild Intermittent Hypoxia Exposure on the Abdominal Subcutaneous Adipose Tissue Proteome in Overweight and Obese Men: A First-in-Human Randomized, Single-Blind, and Cross-Over Study
por: Van Meijel, Rens L. J., et al.
Publicado: (2022)

Effects of gut microbiota manipulation on ex vivo lipolysis in human abdominal subcutaneous adipocytes
por: Jocken, Johan W. E., et al.
Publicado: (2018)

The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
por: González Hernández, Manuel A., et al.
Publicado: (2019)

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
por: Jung, Jin Ah, et al.
Publicado: (2015)

The PERSonalized Glucose Optimization Through Nutritional Intervention (PERSON) Study: Rationale, Design and Preliminary Screening Results
por: Gijbels, Anouk, et al.
Publicado: (2021)

The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects
por: Langenickel, Thomas H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ggnmmss4fsfadj4og0arduq0d6